Xponance Inc. Buys 1,649 Shares of Oscar Health, Inc. (NYSE:OSCR)

Xponance Inc. boosted its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 12.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,394 shares of the company’s stock after purchasing an additional 1,649 shares during the quarter. Xponance Inc.’s holdings in Oscar Health were worth $193,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in OSCR. KBC Group NV increased its position in shares of Oscar Health by 56.1% during the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock worth $96,000 after purchasing an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC acquired a new position in Oscar Health during the 4th quarter valued at about $100,000. Alberta Investment Management Corp purchased a new stake in Oscar Health in the fourth quarter valued at about $138,000. FORA Capital LLC acquired a new stake in Oscar Health in the third quarter worth about $237,000. Finally, SMART Wealth LLC purchased a new stake in shares of Oscar Health during the fourth quarter worth about $180,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on OSCR shares. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and decreased their price objective for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Jefferies Financial Group started coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target for the company. Two research analysts have rated the stock with a sell rating, three have issued a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Oscar Health presently has an average rating of “Hold” and a consensus target price of $20.21.

Oscar Health Price Performance

NYSE:OSCR opened at $13.29 on Friday. The firm’s fifty day moving average is $14.90 and its two-hundred day moving average is $16.09. The firm has a market cap of $3.33 billion, a price-to-earnings ratio of -663.92 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health, Inc. has a one year low of $12.43 and a one year high of $23.79.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.